For example, RUNX1 has been shown to regulate the estrogen receptor-positive luminal lineage, and RUNX1 mutations may present as an additional genetic predisposition in breast cancer development (Van Bragt et al., 2014). The gene discussed is ESR1; the disease is breast cancer.